Joel Greenblatt Invitae Corp Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.42 - $0.72 $5,212 - $8,935
12,411 Added 112.91%
23,403 $14,000
Q3 2023

Nov 14, 2023
BUY
$0.6 - $1.53 $6,595 - $16,817
10,992 New
10,992 $6,000
Q2 2019

Aug 14, 2019
SELL
$17.37 - $26.27 $166,161 - $251,298
-9,566 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$10.65 - $25.75 $101,877 - $246,324
9,566 New
9,566 $224,000

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email